Close Menu

CHICAGO (GenomeWeb) – DNAnexus, maker of a cloud-based genome informatics and data management platform, has closed a $58 million round of venture capital.

New investor Foresite Capital led the round, while Microsoft made a "strategic investment," Mountain View, California-based DNAnexus said today. Previous investors GV — formerly Google Ventures — TPG Biotech, WuXi NextCode, Claremont Creek Ventures, and MidCap Financial also took part in the financing.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.

There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.

The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.

In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.